Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EFCAB5 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | ZNF829 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | GNAO1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | CDK5R1 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | USP37 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | MVB12B | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | ZNF565 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | MRPS21 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | ZNF724 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |